Search Medical Condition
Please enter condition
Please choose location from dropdown

Benito Juarez, Mexico Clinical Trials

A listing of Benito Juarez, Mexico clinical trials actively recruiting patients volunteers.

RESULTS

Found (295) clinical trials

Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy

The use of contrast media is more frequent as new diagnostic and therapeutic procedures are developed. As a consequence, the occurrence of acute renal failure (ARF), also known as contrast-induced nephropathy, is more frequently seen after the realization of these procedures, representing about 10% of all in-hospital ARF. The importance ...

Phase

2.22 miles

Learn More »

Treatment of Good Prognosis BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Treatment with rituximab and chemotherapy (R-CHOP)is the accepted treatment for young patients with diffuse large B cell Non-Hodgkin's Lymphoma. However not every patient benefits with this expensive therapy. Recent data suggest that patients with BCL-6 negative lymphoma are more sensitive to Rituximab therapy. It is also known that patients with ...

Phase

2.22 miles

Learn More »

Correlation Between Access Blood Flow and Extracorporeal Blood Flow

Accesses that show a large (>15%) decrement over time in vascular access blood flow are associated with a high risk of thrombosis. Serial measurements of vascular access blood flow predict access thrombosis. At the moment, the measurement of access flow is time consuming, operator dependent, so that it cannot be ...

Phase N/A

2.22 miles

Learn More »

Hydralazine Valproate for Cervical Cancer

Randomized, double-blind phase III trial. A total of 143 patients (alpha 0.5, power 0.8)with metastatic, persistent or recurrent cervical cancer without previous systemic treatment will be randomized to cisplatin topotecan + placebo or cisplatin topotecan hydralazine valproate for 6 courses every 3 weeks. Patients will receive an oral dose of ...

Phase

2.22 miles

Learn More »

Hydralazine Valproate for Ovarian Cancer

Randomized, double-blind phase III trial. A total of 211 patients (alpha 0.5, power 0.8)with cisplatin-resistant recurrent or persistent cancer will be randomized to topotecan + placebo or topotecan + hydralazine + valproate for 6 courses every 4 weeks. Patients will receive an oral dose of hydralazine of 182mg (rapid) or ...

Phase

2.22 miles

Learn More »

Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors

This is a prospective diagnostic test study. Inclusion criteria are all consecutive patients with parotid gland masses referred for treatment at our center, from January 2003 to December 2007. The gold standard for the diagnosis of malignancy is the surgical pathology report of the parotidectomy specimen. Cytologist and pathologist will ...

Phase

2.22 miles

Learn More »

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to collect additional safety data until apalutamide is commercially available for participants with non-metastatic castrate-resistant prostate cancer (NM-CRPC).

Phase

2.22 miles

Learn More »

Oral dIuretics in Very Intensive Treatment an Early Intervention in Outpatients With Heart Failure

In selected patients who sign informed consent with decompensation of cardiac failure by water congestion will be allocated in two groups: Bumetanide and the other Indapamide group. Each group will be given the maximum tolerated dose for seven days with clinical evaluations every 48 hours. (Face to face and/or telephone). ...

Phase

2.22 miles

Learn More »

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

Nausea and vomiting are common complications on the chemotherapy (CT) and can affect the quality of life (QoL) of the patients. If not treated adequately Nausea and vomiting can produce other problems such as dehydration, weight loss, fatigue and even can induce the non-compliance of the treatment. In extreme cases ...

Phase

2.22 miles

Learn More »

Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatitis

Double-blind clinical trial. Two groups: GROUP A (standard treatment): Prednisone 40 mg a day + Placebo (manufactured by the same laboratory with the same presentation and physical appearance as the nanoemulsified pomegranate seed oil rich in Omega 5 fatty acid) GROUP B (combined treatment): Prednisone 40 mg per day + ...

Phase N/A

2.22 miles

Learn More »